共 50 条
- [36] Drug Survival Outcomes Associated with the Real-World Use of Ixekizumab, Secukinumab, Guselkumab, and Adalimumab for the Treatment of Plaque Psoriasis in China: A 52-Week Single-Center Retrospective Study CLINICAL COSMETIC AND INVESTIGATIONAL DERMATOLOGY, 2022, 15 : 2245 - 2252